Bisoprolol Fumarate

Bisoprolol Fumarate

Nom du produit Bisoprolol Fumarate
Numéro CAS 104344-23-2
Formule moléculaire C18H31NO4 · ½ C4H4O4
Poids moléculaire 766.96 g/mol (as fumarate salt)
Apparence Poudre cristalline blanche à blanc cassé
Essai (HPLC) 98.0% – 102.0% (on dried basis)
Perte au séchage ≤ 0,5%
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 10 ppm
Solubilité Sparingly soluble in water, freely soluble in methanol, slightly soluble in ethanol
Colis 25 kg net in fiber drum with double polyethylene liner

Besoin d'aide ? Contacter notre équipe

Bisoprolol Fumarate Structure

Synonymes : Bisoprolol fumarate, 104344-23-2, EMD 33512, Bisoce, Bisoprolol hemifumarate, (±)-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol fumarate

Bisoprolol fumarate is a synthetic, cardioselective beta-1 adrenergic receptor blocker belonging to the aminoxypropanol class. It is supplied as a white to off-white crystalline powder, manufactured under cGMP conditions and tested to meet or exceed current pharmacopoeial standards (USP/EP).

As a highly selective beta-1 antagonist, bisoprolol fumarate is a cornerstone API for the treatment of hypertension, chronic stable angina, and heart failure. Its balanced lipophilicity and long half-life make it suitable for once-daily dosing, and it remains a preferred choice among healthcare professionals for cardiovascular management.

Product Highlights

  • High purity: ≥98.0% assay, with tight control on related substances and residual solvents.
  • Regulatory support: Available with DMF (Type II) and CEP, suitable for ANDA and generic filings.
  • Stable supply: Commercial-scale production with a current capacity of 20 metric tons per year.
  • Quality assurance: Each batch is fully traceable, with full documentation and retained samples.
  • Competitive pricing: Direct from manufacturer, offering cost advantages for bulk orders.

Applications

  • Treatment of essential hypertension, either as monotherapy or in combination with other antihypertensives.
  • Management of chronic stable angina pectoris.
  • Adjunct therapy in stable chronic heart failure with reduced ejection fraction.
  • Formulation of immediate-release and fixed-dose combination tablets.
  • Research on beta-adrenergic receptor pharmacology and cardiovascular therapeutics.

Caractéristiques techniques

Paramètre Spécifications
Assay (HPLC, dried basis) 98.0% – 102.0%
Apparence Poudre cristalline blanche à blanc cassé
Identification IR and HPLC retention time match reference standard
Perte au séchage ≤ 0,5%
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 10 ppm
Substances apparentées Each impurity ≤ 0.5%, total ≤ 1.0%

Ordering & Supply

  • Emballage: 25 kg net in fiber drum with double polyethylene liner; custom packaging available upon request.
  • Quantité minimale de commande: 1 kg for trial orders; 25 kg for commercial orders.
  • Délai de livraison: 3 à 5 jours ouvrés (articles en stock)
  • Documentation: COA, MSDS, TDS, and regulatory support (DMF, CEP) provided with each shipment.

Demande de devis

RESTEZ EN CONTACT

Demande de devis

Notre adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×